Provided by Tiger Trade Technology Pte. Ltd.

Quince Therapeutics, Inc.

30.68
-0.3300-1.06%
Pre-market: 30.50-0.1800-0.59%05:24 EDT
Volume:20.92K
Turnover:632.34K
Market Cap:31.20M
PE:-0.34
High:31.99
Open:31.99
Low:29.20
Close:31.01
52wk High:909.98
52wk Low:15.10
Shares:1.02M
Float Shares:679.70K
Volume Ratio:1.11
T/O Rate:3.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-90.9250
EPS(LYR):-335.2669
ROE:-153.84%
ROA:-31.51%
PB:-0.88
PE(LYR):-0.09

Loading ...

Leerink Partners Reaffirms Their Buy Rating on Quince Therapeutics (QNCX)

TIPRANKS
·
Sep 30

Quince Therapeutics to Host Virtual KOL Event on PH-ILD, BOS Treatment Landscape and LAM-001

Reuters
·
Sep 17

Quince Therapeutics Flags NASDAQ Noncompliance After Stockholders’ Equity Falls to ($35.32 Million)

Reuters
·
Sep 04

Quince Therapeutics President Charles Ryan to Exit Sept. 8

Reuters
·
Aug 28

Quince Therapeutics Announces Special Shareholder Meeting

Reuters
·
Aug 25

Craig-Hallum bullish on Quince Therapeutics, initiates with a Buy

TIPRANKS
·
Aug 20

Quince Therapeutics : Leerink Partners Adjusts Target Price to $68 from $4 to Reflect 1-for-20 Reverse Stock Split

THOMSON REUTERS
·
Aug 18

Quince Therapeutics Raises USD 115 Million in Private Placement of Series C Preferred Shares

Reuters
·
Aug 17

Quince Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Quince Therapeutics Q2 Net Loss Widens on Acquisition Charges

Reuters
·
Aug 14

Press Release: Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update

Dow Jones
·
Aug 14

Quince Therapeutics, Inc. Expected to Post a Loss of $17.88 a Share - Earnings Preview

Reuters
·
Aug 07

Quince Therapeutics - Brigette Roberts Conditionally Appointed as Chief Executive Officer - SEC Filing

THOMSON REUTERS
·
Aug 01

Quince Therapeutics Names Brigette Roberts CEO in Management Reshuffle

Reuters
·
Aug 01

Quince Therapeutics Announces Special Shareholder Meeting

Reuters
·
Aug 01

Quince Therapeutics - Offers 15,470,099 Shares of Common Stock for Resale - SEC Filing

THOMSON REUTERS
·
Aug 01

Analysts Offer Insights on Healthcare Companies: Quince Therapeutics (QNCX) and Opus Genetics (IRD)

TIPRANKS
·
Jul 31

Quince Therapeutics : Oppenheimer Initiates Coverage with Outperform Rating; Price Target $82

THOMSON REUTERS
·
Jul 29

Quince Therapeutics Appoints Paul Yu to Chair New Pulmonary Scientific Advisory Board

Reuters
·
Jun 30

Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board

THOMSON REUTERS
·
Jun 30